Anti-EGFR Antibody Efficiently and Specifically Inhibits Human TSC2−/− Smooth Muscle Cell Proliferation. Possible Treatment Options for TSC and LAM
Elena Lesma(Ospedale San Paolo), Alfredo Gorio(University of Milan)
Cited by 26
Related Papers
Cancer Cells Exploit Notch Signaling to Redefine a Supportive Cytokine Milieu
|Frontiers in Immunology|2018|64
Anti-EGFR Antibody Reduces Lung Nodules by Inhibition of EGFR-Pathway in a Model of Lymphangioleiomyomatosis
|BioMed Research International|2015|18
LAM Cells as Potential Drivers of Senescence in Lymphangioleiomyomatosis Microenvironment
|International Journal of Molecular Sciences|2022|8
Primary TSC2-/meth Cells Induce Follicular Neogenesis in an Innovative TSC Mouse Model
|International Journal of Molecular Sciences|2022|3